Researchers receiving grants from the National Institutes of Health would face tougher disclosure rules under an amendment to the economic stimulus bill introduced by Sens. Chuck Grassley (R-IA) and Herb Kohl (D-WI). The legislation would mandate that all grantees receiving funds in excess of $250,000 disclose the amount of the primary investigator’s significant financial interest in companies relevant to the research.
From the March 01, 2009 Issue of MM+M - Medical Marketing and Media
